Live Breaking News & Updates on Zegbeh Jallah Roth Capital Partners|Page 1

Operator
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics First Quarter 2021 Earnings Conference Call. [Operator Instructions]. I will now turn the call over to your host, Malin Deon with Jounce Therapeutics. Please go ahead.
Malin Deon
Manager, Investor Relations & Corporate Communications
Thank you, operator. Good morning, and welcome to the Jounce Therapeutics first quarter conference call. This morning we issued a press release which outlines the topics that we plan to discuss today. The release is available in the Investors and Media section of our website at www.jouncetx.com.
Speaking on today s call will be our CEO and President, Dr. Rich Murray, who will review our pipeline progress, and key milestones, followed by our CSO, Dr. Dmitri Wiederschain, who will discuss our discovery efforts. Our CMO, Dr. Beth Trehu will then provide an update on our clinical activities, and lastly, our CFO, Kim Drapkin will review our first quar ....

Erich Murray , Raymond James , Edward Tenthoff Piper Sandler , Steve Seedhouse , Dmitri Wiederschain , Dmitri Wiederschainside , Swayam Ramakanth , Richard Murray , Nick Abbott , Beth Trehu , Kim Drapkin , Piper Sandler , Ryan Deschner , Zegbeh Jallah , Elizabeth Trehu , Malin Deon , Ted Tenthoff , Colleen Casey , Ryan Deschner Raymond James Financial Inc Analyst , Boris Peaker Cowen Co , Zegbeh Jallah Roth Capital Partners , Ramakanth Swayampakula Hc Wainwright Co , Investor Relations Corporate Communications , Jounce Therapeutics Inc , Jounce Therapeutics , Jounce Therapeutics First Quarter ,